$31.49
-0.18[-0.57%]
At close: Apr 26
$31.49
0[0.00%]
After Hours: 4:00PM EDT
Agios Pharmaceuticals: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 10, 2024 | Jacqualyn Fouse | DIRECTOR | 8.143K | $27.55 | -$214.64K | SELL-OPTIONS | 6.30% | 137.396K | Apr 08 - Apr 10 | View |
Mar 11, 2024 | Kaye FosterCheek | DIRECTOR | -1.285K | $31.62 | -$40.63K | SELL | -14.26% | 7.724K | Mar 07 | View |
Mar 07, 2024 | Kaye FosterCheek | DIRECTOR | -4.715K | $32.00 | -$150.90K | SELL | -34.36% | 9.009K | Mar 05 - Mar 06 | View |
Mar 07, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -1.913K | $31.75 | -$60.74K | SELL | -39.86% | 2.886K | Mar 05 | View |
Mar 05, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 5.192K | $32.57 | -$86.05K | SELL-OPTIONS | 15.33% | 39.066K | Mar 01 - Mar 05 | View |
Mar 05, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 1.328K | $32.57 | -$21.89K | SELL-OPTIONS | 9.83% | 14.84K | Mar 01 - Mar 05 | View |
Mar 05, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 1.913K | $32.57 | -$39.54K | SELL-OPTIONS | 66.29% | 4.799K | Mar 01 - Mar 05 | View |
Mar 05, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 4.344K | $32.57 | -$135.36K | SELL-OPTIONS | 8.79% | 53.78K | Mar 01 - Mar 05 | View |
Mar 05, 2024 | James Burns | CHIEF LEGAL OFFICER | 5.192K | $32.57 | -$86.05K | SELL-OPTIONS | 16.24% | 37.169K | Mar 01 - Mar 05 | View |
Feb 29, 2024 | David Schenkein | DIRECTOR | 0 | $33.15 | -$210.02K | SELL-OPTIONS | 0.00% | 201.936K | Feb 27 | View |
Feb 27, 2024 | David Schenkein | DIRECTOR | 0 | $32.37 | -$98.94K | SELL-OPTIONS | 0.00% | 201.936K | Feb 23 - Feb 26 | View |
Feb 22, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -504 | $26.63 | -$13.42K | SELL | -15.53% | 2.741K | Feb 20 | View |
Feb 14, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 1.52K | $25.14 | -$16.14K | SELL-OPTIONS | 4.76% | 33.431K | Feb 12 - Feb 14 | View |
Feb 14, 2024 | James Burns | CHIEF LEGAL OFFICER | 1.288K | $25.14 | -$13.70K | SELL-OPTIONS | 4.24% | 31.666K | Feb 12 - Feb 14 | View |
Feb 14, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 504 | $25.14 | -$6.86K | SELL-OPTIONS | 18.39% | 3.245K | Feb 12 - Feb 14 | View |
Jan 24, 2024 | James Burns | CHIEF LEGAL OFFICER | 4.042K | $21.64 | -$36.96K | SELL-OPTIONS | 15.35% | 30.378K | Jan 20 - Jan 24 | View |
Jan 24, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.042K | $21.64 | -$36.96K | SELL-OPTIONS | 14.50% | 31.911K | Jan 20 - Jan 24 | View |
Jan 24, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 3.494K | $21.64 | -$40.81K | SELL-OPTIONS | 36.49% | 13.069K | Jan 20 - Jan 24 | View |
Jan 24, 2024 | Jacqualyn Fouse | DIRECTOR | 13.178K | $21.64 | -$232.02K | SELL-OPTIONS | 11.35% | 129.253K | Jan 20 - Jan 24 | View |
Browse insider trades on all stocks.